Atlas Trials

Beijing Northland Biotech. Co., Ltd.

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Beijing Northland Biotech. Co., Ltd.

RecordFirmDate
Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction (NCT07586865)Beijing Northland Biotech. Co., Ltd.2026-05-18
Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients (NCT05968118)Beijing Northland Biotech. Co., Ltd.2022-07-29
Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction (NCT05984134)Beijing Northland Biotech. Co., Ltd.2022-07-15
Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction (NCT05485818)Beijing Northland Biotech. Co., Ltd.2020-11-23
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2) (NCT04274049)Beijing Northland Biotech. Co., Ltd.2019-08-28
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1) (NCT04275323)Beijing Northland Biotech. Co., Ltd.2019-08-02
A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers (NCT04555850)Beijing Northland Biotech. Co., Ltd.2018-07-30

Track Beijing Northland Biotech. Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.